Latest Administration News

SelfWealth Ltd reported a 4% revenue increase and sustained profitability in H1 2025, while advancing a major transformation program and entering a proposed acquisition deal with Bell Financial Group.

SelfWealth Limited reported a modest revenue increase for the half-year ended December 2024, yet profits plunged sharply due to higher operating expenses as the company prepares for a potential acquisition by Bell Financial Group.

Icetana Limited reports a sharp decline in cash flow for the December quarter, offset by plans for an underwritten rights issue to bolster funding and expectations of improved customer receipts in coming quarters.

Firetail Resources has sold its lithium rights over key Western Australian projects to Spartan Resources for $275,000, marking a strategic shift to focus on its flagship Skyline Copper Project in Canada.

Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.

NuEnergy Gas Limited reported a $279,000 net cash outflow from operations in Q4 2024, maintaining a solid cash balance of $4.89 million. The company continues to rely on loans and capital management to fund its coal bed methane exploration activities.

Audeara has officially launched its Clinico Sound Earbuds CS1 in Taiwan through a strategic partnership with Clinico Inc., marking a key step in its international expansion and tapping into a growing hearing health market.

Spectur Limited reported a robust net cash inflow from operating activities of $2.53 million in Q4 2024, offsetting modest outflows in investing and financing activities. The company closed the quarter with $869,000 in cash and cash equivalents, signaling operational resilience in the surveillance technology sector.

Invex Therapeutics reports encouraging results from its collaboration with Tessara Therapeutics, showing Exenatide’s potential to improve neuronal survival in a 3D human brain model of Alzheimer's disease. The company maintains a stable cash position while exploring new neurological partnerships.

LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.

West African Resources Limited reported a robust cash position of A$391.7 million at the end of December 2024, despite significant outflows driven by exploration and operational costs. The company maintains substantial financing facilities, positioning it well for ongoing development.

Alicanto Minerals has intensified its project acquisition efforts and advanced exploration at its Greater Falun and Sala projects in Sweden, supported by a recent capital raise and strategic leadership appointment.